Hemofília: vizsgálatok itt: Ausztria
11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Innsbruck, Vienna
- Életkor
- 12 év and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - 3. fázisTaking peopleEfanesoctocog alfa treatment in patients with congenital hemophilia A suffering from inflammation of joint lining
- Where
- Graz, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- GWT-Tud GmbH
See details and how to join2025-523896-44-00 · EU 2025-523896-44-00 - 3. fázisTaking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Wien
- Életkor
- 1 év to 74 év
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Vienna
- Életkor
- 12 év and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - 3. fázisTaking peoplePhase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- Where
- Vienna
- Életkor
- 138 hónap to 206 hónap
- People
- 20 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07080905 · EU 2023-505805-18-00 - 3. fázisTaking peopleA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Vienna
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - 1. fázisTaking peopleA Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Where
- Innsbruck, Vienna
- Életkor
- 18 év to 64 év
- People
- 30 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07220564 · EU 2025-520490-38-00 - No phaseCsak meghívásosA Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
- Where
- Vienna
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03745924 - No phaseTaking peopleAn Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938 - No phaseCsak meghívásosA Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
- Where
- Vienna
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT04574076 - No phaseTaking peopleThe European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Graz, Vienna
- People
- 4000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119